Replies to post #58 on Catalyst Biosciences Inc (CBIO)

[The Night Stalker]

Cash, cash equivalents and short-term investments as of June 30, 2016, were $24.0 million. The company believes that its existing capital resources will be sufficient to meet its projected operating requirements for at least the next 12 months.

[The Night Stalker]

trials only in phase 1?

[The Night Stalker]

As of July 29, 2016, the number of outstanding shares of the registrant’s common stock, par value $0.001 per share, was 11,835,864.

100m A/S small assets tiny liabilties deal

sold off assets of 1m back in august .... just doing DD

[TheFinalCD]

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123220057

[Lone Wolf]

Oh shoot...didn't even realize you had been in on this one. Didn't scroll down to peep out the board. Very interesting licensing deal. Readying something for 'commercialization'? Hmmmm.

$CBIO